Reliable, cost-effective population genomic insights to support confident decisions

Researchers worldwide are advancing population genomics studies in focused ethnic or geographic populations to reveal new insights into the interplay between the genetics of disease and lifestyle factors with the help of Thermo Fisher Scientific.

 

Predictive genomics holds tremendous promise. Major developments are driving new studies using polygenic risk scores (PRSs) as a clinical research tool. Rich data is helping researchers assemble large, longitudinal cohorts needed to verify and test PRSs.

 

The genetic information held in large biobanks makes rich data sets of billions of genotypes available to scientists for a wide range of research applications. Scientists from many of the world’s largest population genetic epidemiology projects have chosen Thermo Fisher Scientific to tailor the array design for their studies.  

Benefits & workflow

 

 

neon-benefits-workflow

Customer & solutions overview

Importance of imputation accuracy

In this webinar, Dr. Nam of GeneStory, Vietnam, explains imputation's impact on genotyping array accuracy, factors for selecting a suitable array, and a country's experience analyzing PRS in under-represented populations.

Smarter is better than larger: How imputation-aware whole-genome genotyping bridges the gap between sequencing and targeted panels

Genotyping techniques used by researchers

In this webinar series, learn how genotyping techniques, including microarray analysis, next‑generation sequencing, and quantitative and digital PCR, are being used by researchers in different applications

Understanding a shifting tech landscape

In this webinar we introduce three key whole-genome technologies and discuss how they can be integrated into technology strategies for your research.

Which technology platform is right for you?


Explore the advances and trade-offs of three different technologies in the context of genomic discovery.

 

Microarrays—an essential tool for predictive genomics

Steve Jackson, PhD. talks about the microarray and it’s growth as a predictive genomics powerhouse and global studies in population-based testing and pharmacogenomics.

Custom arrays

 

 

 

Microarray Research Services Laboratory